Article

Integrating Functional Protein Drug Target Data into a Precision Oncology Molecular Tumor Board

2024-10-18

Abstract excerpt

Collaborative review of molecular profiling data by multidisciplinary molecular tumor boards (MTB) is increasingly important for improving patient management and outcomes, though currently relies nearly exclusively on nucleic acid next-generation sequencing (NGS) and limited panels of immunohistochemistry-based protein abundance data. We examined the feasibility of incorporating real-time laser microdissection (LM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8818e50d-6f05-5978-81dc-aa546c0f1bc2
DOI: 10.1101/2024.10.17.24315608

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating Functional Protein Drug Target Data into a Precision Oncology Molecular Tumor BoardDOI 10.1101/2024.10.17.24315608Read

Molecular profiling for precision cancer therapiesSemantic proximity Read

The molecular tumor board—a key element of precision oncologySemantic proximity Read

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.Semantic proximity Read

Precision oncology based on omics data: The NCT Heidelberg experienceSemantic proximity Read

Integration of proteomics in the molecular tumor boardSemantic proximity Read

TOPAS: phosphoproteome data analysis and decision support platform for molecular tumor boardsSemantic proximity Read

Molecular profiling of clinical tissues specimens: feasibility and applications.Semantic proximity Read

Molecular Tumor Boards: Realizing Precision Oncology Therapy.Semantic proximity Read

Molecular pathology as the driving force for personalized oncology.Semantic proximity Read

Expanding individualized therapeutic options via genoproteomics.Semantic proximity Read

Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy ResponseSemantic proximity Read

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.Semantic proximity Read